Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients

The use of tacrolimus (Tac) may be involved in the development of new-onset diabetes after transplantation (NODAT) in a dose-related manner. This study aimed to evaluate the effects of a standard twice-daily formulation of Tac (TacBID) vs. the once-daily slow-release formulation (TacOD) on the basal...

Full description

Bibliographic Details
Main Authors: Valeria Cademartori, Fabio Massarino, Emanuele L. Parodi, Ernesto Paoletti, Rodolfo Russo, Antonella Sofia, Iris Fontana, Francesca Viazzi, Pasquale Esposito, Giacomo Garibotto
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Transplantology
Subjects:
Online Access:https://www.mdpi.com/2673-3943/2/1/5